
Evolus advances facial aesthetics with Evolysse Sculpt, a new hyaluronic acid gel targeting mid-face volume loss, pending FDA approval.
Marie Bosslett is the assistant editor of Dermatology Times® and joined the MJH Life Sciences team in October 2024. She attended Loyola University Maryland in Baltimore and earned a Bachelor of Arts in Communication with minors in marketing and writing. When she’s not writing, Marie enjoys going to concerts, reading on the beach, and spending time with friends and family.

Evolus advances facial aesthetics with Evolysse Sculpt, a new hyaluronic acid gel targeting mid-face volume loss, pending FDA approval.

This review of the latest dermatologic studies includes a case study of coexisting alopecia and BP treatment, hypochlorous acid for epidermolysis bullosa wounds, DMG-Na and caffeine for hair loss, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore expert insights from Adam Friedman, MD, FAAD, on emerging topical treatments for atopic dermatitis, featuring real-world cases and practical strategies for improving care and access.

Dr. Rossi DERM MD blends dermatologic science with K-beauty aesthetics for effective, evidence-based solutions.

Explore the latest advancements in psoriasis treatment with innovative topical therapies, enhancing patient outcomes and simplifying management for diverse skin types.

Answer today's poll and explore the evolving aesthetic trends among Millennials and Gen Z, focusing on their unique preferences for skin care, fillers, and Botox treatments.

Discover Anthony Rossi, MD, FAAD, FACMS's innovative skin care line targeting inflammatory aging with clinical science, clean formulations, and effective anti-aging solutions.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

In case you missed it, this week we had news about the first annual GPP Awareness Day, a warning from the FDA on whipped sunscreens, the accuracy of vitiligo video content on TikTok, and more.

The latest study reveals the link between cosmetic use and acne, highlighting the risks of comedogenic ingredients in moisturizers, facial cleansers, and powders.

Discover how internet-based therapy effectively treats dermatological BFRBs like trichotillomania and dermatillomania, enhancing patient outcomes and accessibility.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Irina Mazur spoke to Dermatology Times about the latest partnership, which aims to bridge the gap between clinical advice and patient behavior through personalized sun protection guidance.

Shannon C. Trotter, DO, FAOCD, FAAD, and patient Janene Tirado, highlight GPP Awareness Day and the urgent need for recognition and understanding of generalized pustular psoriasis.

TikTok's vitiligo content reveals a critical need for reliable clinical information from HCPs, highlighting the gap between engagement and accuracy in health education.

Merck's pembrolizumab gains Health Canada approval for innovative perioperative treatment of advanced head and neck squamous cell carcinoma, enhancing patient outcomes.

This review of the latest dermatologic studies includes findings on cybersecurity practices in dermatology, compression therapy for cellulitis, melanoma overdiagnosis, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

New 76-week data reveals guselkumab's significant benefits for plaque psoriasis, enhancing clinical outcomes, improving quality of life, and reducing stigmatization.

IKI Skin Care by Maria Urbani, MD offers effective solutions for rosacea and sensitive skin through science-backed, minimalist formulations.

Nektar Therapeutics and Jonathan Zalevsky, PhD, are exploring REZPEG's potential in treating alopecia, atopic dermatitis, lupus, and diabetes, aiming for groundbreaking autoimmune therapies.

In case you missed it, this week we had news about a novel PDE4 inhibitor for plaque psoriasis, the evolution of 5-ALA, a new melanoma treatment plan combining vidutolimod with pembrolizumab, and more.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Nektar Therapeutics explores rezpegaldesleukin's potential as a groundbreaking treatment for alopecia areata, aiming for FDA approval and improved patient outcomes.

Discover the promising results of ME3183, a novel oral treatment for plaque psoriasis, showing significant efficacy and safety in a recent study.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

In this exclusive Q&A, Alan J. Bauman, MD, shares expert insights on innovative hair loss treatments, early intervention strategies, and the future of alopecia care.

Discover how Rolf-Markus Szeimies, MD, is revolutionizing at-home skin care with 5-ALA, enhancing cellular health and hydration in daily routines.

This review of the latest dermatologic studies includes a review of photoprotection in patients with skin of color, the presence of inflammatory cytokines in acne patients after isotretinoin treatment, perceptions of skin-lightening products in medical students, and more.